← Back to Patent Explorer
US4618607A Expired / Lapsed US ⏱️ 0.0 years remaining

1,4-dihydropyridine-3,5-dicarboxylic acid ester derivatives and pharmaceutical compositions

Assignee: Tanabe Pharma Corp
•
Filing: 1982-12-10
•
Granted: 1986-10-21
•
Expires: 2002-12-10
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract 1,4-Dihydropyridine-3,5-dicarboxylic acid ester derivatives of the general formula: <IMAGE> or acid addition salts thereof, wherein W is -CH= or -N=; Y is -CH=CH-, -O-, -S-, -CH=N(O)p- (p is zero or 1) or -N(R)- (R is hydrogen or lower alkyl); X1, X2 and X3 are the same or different, and are each hydrogen, halogen, nitro, trifluoromethyl, cyano or lower alkylthio; Z is aryl or 5- or 6-membered aromatic heterocyclic ring (which may have a substituent or two or three substituents which may be the same or different, and the substituent may be halogen, lower alkyl, lower alkoxy, lower alkanoylamino, cyano, nitro, lower alkylthio, trifluoromethyl, sulfamoyl, di-lower alkylsulfamoyl, amino or di-lower alkylamino); <IMAGE> is 5- to 7-membered heterocyclic ring which may have nitrogen atom, oxygen atom, sulfur atom or unsaturated bond on the ring, and may be substituted by lower alkyl, lower alkoxycarbonyl, lower alkanoylamino, ethylenedioxy or -(CH2)m-OR4 (R4 is hydrogen, lower alkyl or lower alkanoyl and m is 0, 1 or 2); R1 and R2 are the same or different, and are each lower alkyl; R3 is lower alkyl, aralkyl, heteroaralkyl; and n is an integer 1 to 5. Such compounds are useful as antihypertensive agents and as therapeutic agents for cardiac and cerebral circulation disorders.

Inventors

  • 👤 Kazuhiko Araki
  • 👤 Hideki Ao
  • 👤 Jun Inui
  • 👤 Kenichi Aihara

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-26 11:36
CPC Classifications
C; C07; C07D; C07D213/00; C07D213/02; C07D213/89; C07D211/00; C07D211/04; C07D211/80; C07D211/84; C07D211/90; C07D401/00; C07D401/02; C07D401/04; C07D401/12; C07D405/00; C07D405/02; C07D405/04; C07D405/12; C07D407/00; C07D407/02; C07D407/12; C07D409/00; C07D409/02; C07D409/04; C07D409/12; C07D409/14; C07D413/00; C07D413/02; C07D413/12; C07D417/00; C07D417/02; C07D417/04; C07D417/12; C07D491/00; C07D491/02; C07D491/10

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 196 words
A 1,4-dihydropyridine-3,5-dicarboxylic acid ester derivative of the general formula: ##STR17## or a pharmaceutically acceptable acid addition salt thereof, wherein W is --CH═; Y is --CH═CH--, --O--, --S--, --CH═N or --N(R)-- (R is hydrogen or lower alkyl); X 1 , X 2 and X 3 are the same or different, and are each hydrogen, halogen, nitro, trifluoromethyl, cyano or lower alkylthio; Z is aryl or 5- or 6-membered aromatic heterocyclic ring (which may have a substituent or two or three substituents which are the same or different, and the substituent may be halogen, lower alkyl, lower alkoxy, lower alkanoylamino, cyano, nitro, lower alkylthio, trifluoromethyl, sulfamoyl, di-lower alkyl-sulfamoyl, amino or di-lower alkylamino); ##STR18## is 5- to 7-membered heterocyclic ring which may have nitrogen atom, oxygen atom, or sulfur atom on the ring and may be substituted by lower alkyl, lower alkoxycarbonyl, lower alkanoylamino, ethylenedioxy or --(CH 2 ) m --OR 4 (R 4 is hydrogen, lower alkyl or lower alkanoyl and m is 0, 1 or 2); R 1 and R 2 are the same or different and are each lower alkyl; R 3 is lower alkyl, aralkyl or heteroalkyl; and n is an integer 1 to 5.
Claim 2
Dependent Claim 196 words
A 1,4-dihydropyridine-3,5-dicarboxylic acid ester derivative of the general formula: ##STR17## or a pharmaceutically acceptable acid addition salt thereof, wherein W is --CH═; Y is --CH═CH--, --O--, --S--, --CH═N or --N(R)-- (R is hydrogen or lower alkyl); X 1 , X 2 and X 3 are the same or different, and are each hydrogen, halogen, nitro, trifluoromethyl, cyano or lower alkylthio; Z is aryl or 5- or 6-membered aromatic heterocyclic ring (which may have a substituent or two or three substituents which are the same or different, and the substituent may be halogen, lower alkyl, lower alkoxy, lower alkanoylamino, cyano, nitro, lower alkylthio, trifluoromethyl, sulfamoyl, di-lower alkyl-sulfamoyl, amino or di-lower alkylamino); ##STR18## is 5- to 7-membered heterocyclic ring which may have nitrogen atom, oxygen atom, or sulfur atom on the ring and may be substituted by lower alkyl, lower alkoxycarbonyl, lower alkanoylamino, ethylenedioxy or --(CH 2 ) m --OR 4 (R 4 is hydrogen, lower alkyl or lower alkanoyl and m is 0, 1 or 2); R 1 and R 2 are the same or different and are each lower alkyl; R 3 is lower alkyl, aralkyl or heteroalkyl; and n is an integer 1 to 5.
Claim 3
Dependent Claim 7 words
The compound of claim 1: 2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid-3-methylester-5-(1-phenyl-2-piperidinoethyl)ester.
Claim 4
Dependent Claim 7 words
The compound of claim 1: 2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid-3-methylester-5-[1-(2-thienyl)-2-piperidinoethyl]ester.
Claim 5
Dependent Claim 7 words
The compound of claim 1: 2,6-dimethyl-4-(m-nitropheny)-1,4-dihydropyridine-3,5-dicarboxylic acid-3-methylester-5-[1-(2-furyl)-2-piperidinoethyl]ester.
Claim 6
Dependent Claim 7 words
The compound of claim 1: 2,6-dimethyl-4-(2-thienyl)-1,4-dihydropyridine-3,5-dicarboxylic acid-3-methylester-5-(1-phenyl-2-piperidinoethyl)ester.
Claim 7
Dependent Claim 7 words
The compound of claim 1: 2,6-dimethyl-4-(2-furyl)-1,4-dihydropyridine-3,5-dicarboxylic acid-3-methylester-5-(1-phenyl-2-piperidinoethyl)ester.
Claim 8
Dependent Claim 26 words
A pharmaceutical composition comprising the compound of claim 1 in combination with a pharmaceutically acceptable inert carrier, said compound being present in a therapeutically effective amount.

References Cited (Backward Citations)

GB1383625A Cited
US4038399A Cited
US4450165A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1989-10-20 1990-04-21 1990-10-21 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1993-10-20 1994-04-21 1994-10-21 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1997-10-20 1998-04-21 1998-10-21 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag